论文信息 - Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC). - 字舞流文

Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC).

S. Baylin | M. Brock | C. Rudin | S. Belinsky | M. Rudek | R. Juergens | F. Vendetti | B. Coleman | R. Sebree | J. Herman